BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35012890)

  • 1. Quantitative brain MRI morphology in severe and attenuated forms of mucopolysaccharidosis type I.
    Kovac V; Shapiro EG; Rudser KD; Mueller BA; Eisengart JB; Delaney KA; Ahmed A; King KE; Yund BD; Cowan MJ; Raiman J; Mamak EG; Harmatz PR; Shankar SP; Ali N; Cagle SR; Wozniak JR; Lim KO; Orchard PJ; Whitley CB; Nestrasil I
    Mol Genet Metab; 2022 Feb; 135(2):122-132. PubMed ID: 35012890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
    Yund B; Rudser K; Ahmed A; Kovac V; Nestrasil I; Raiman J; Mamak E; Harmatz P; Steiner R; Lau H; Vekaria P; Wozniak JR; Lim KO; Delaney K; Whitley C; Shapiro EG
    Mol Genet Metab; 2015 Feb; 114(2):170-7. PubMed ID: 25541100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
    Shapiro EG; Nestrasil I; Rudser K; Delaney K; Kovac V; Ahmed A; Yund B; Orchard PJ; Eisengart J; Niklason GR; Raiman J; Mamak E; Cowan MJ; Bailey-Olson M; Harmatz P; Shankar SP; Cagle S; Ali N; Steiner RD; Wozniak J; Lim KO; Whitley CB
    Mol Genet Metab; 2015; 116(1-2):61-8. PubMed ID: 26095521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention and corpus callosum volumes in individuals with mucopolysaccharidosis type I.
    King KE; Rudser KD; Nestrasil I; Kovac V; Delaney KA; Wozniak JR; Mueller BA; Lim KO; Eisengart JB; Mamak EG; Raiman J; Ali N; Cagle S; Harmatz P; Whitley CB; Shapiro EG
    Neurology; 2019 May; 92(20):e2321-e2328. PubMed ID: 30979856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT).
    Shapiro E; Guler OE; Rudser K; Delaney K; Bjoraker K; Whitley C; Tolar J; Orchard P; Provenzale J; Thomas KM
    Mol Genet Metab; 2012 Sep; 107(1-2):116-21. PubMed ID: 22867884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I.
    Nestrasil I; Shapiro E; Svatkova A; Dickson P; Chen A; Wakumoto A; Ahmed A; Stehel E; McNeil S; Gravance C; Maher E
    Am J Med Genet A; 2017 Mar; 173(3):780-783. PubMed ID: 28211988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
    Provenzale JM; Nestrasil I; Chen S; Kan SH; Le SQ; Jens JK; Snella EM; Vondrak KN; Yee JK; Vite CH; Elashoff D; Duan L; Wang RY; Ellinwood NM; Guzman MA; Shapiro EG; Dickson PI
    Exp Neurol; 2015 Nov; 273():1-10. PubMed ID: 26222335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I.
    Vite CH; Nestrasil I; Mlikotic A; Jens JK; Snella EM; Gross W; Shapiro EG; Kovac V; Provenzale JM; Chen S; Le SQ; Kan SH; Banakar S; Wang RY; Haskins ME; Ellinwood NM; Dickson PI
    Comp Med; 2013 Apr; 63(2):163-73. PubMed ID: 23582423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter changes mimicking a leukodystrophy in a patient with Mucopolysaccharidosis: characterization by MRI.
    Barone R; Parano E; Trifiletti RR; Fiumara A; Pavone P
    J Neurol Sci; 2002 Mar; 195(2):171-5. PubMed ID: 11897250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
    Sugijono SE; Mulyadi R; Firdausia S; Prihartono J; Estiasari R
    Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
    Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
    Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of neurocognition in MPS disorders: A review.
    Shapiro EG; Eisengart JB
    Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.
    Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE
    Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging findings suggestive of white matter alterations in a canine model of mucopolysaccharidosis type I.
    Middleton DM; Li JY; Chen SD; White LE; Dickson P; Ellinwood NM; Provenzale JM
    Neuroradiol J; 2018 Feb; 31(1):90-94. PubMed ID: 28695759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.
    Choi J; Dickson P; Calabrese E; Chen S; White L; Ellingwood M; Provenzale JM
    Neuroradiol J; 2015 Dec; 28(6):562-73. PubMed ID: 26475483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?
    Vollebregt AAM; Ebbink BJ; Rizopoulos D; Lequin MH; Aarsen FK; Shapiro EG; van der Ploeg AT; van den Hout JMP
    J Inherit Metab Dis; 2021 May; 44(3):751-762. PubMed ID: 33330992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucopolysaccharidoses: characterization by cranial MR imaging.
    Lee C; Dineen TE; Brack M; Kirsch JE; Runge VM
    AJNR Am J Neuroradiol; 1993; 14(6):1285-92. PubMed ID: 8279321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.